GlassScriptPhysician profile
Amro Alsaid
NPI 1144532474
$30,392.51
in general payments reported to CMS, 2019-2025
14 companies · $28K in 2025
The $28K reported for 2025 was more than what 97% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $105 · 2022: $205 · 2023: $566 · 2024: $1,061 · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Food and Beverage: $3,770 · Travel and Lodging: $1,871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,440.00 |
| Food and Beverage | $3,770.49 |
| Travel and Lodging | $1,871.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cleerly, INC. | $24,475.46 | 2023-2025 | Cleerly Labs, Cleerly Ischemia |
| Heartflow, INC. | $2,803.29 | 2022-2025 | Ffrct |
| Edwards Lifesciences Corporation | $1,488.75 | 2023-2025 | Sapien 3 Ultra Resilia, Evoque |
| Abbott Laboratories | $283.29 | 2022-2025 | Navitor, Amplatzer Amulet |
| Boston Scientific Corporation | $267.90 | 2022-2024 | Watchman Access System |
| Shockwave Medical, INC | $222.25 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Artivion, INC. | $191.53 | 2024 | Cardiac Non-Synergraft |
| Astrazeneca Pharmaceuticals LP | $190.81 | 2020-2022 | |
| Siemens Medical Solutions USA, INC. | $133.58 | 2024 | Magnetom Free.Max, Somatom Pro.Pulse |
| Philips North America LLC | $117.69 | 2024 | (6342) Intrasight Integ, (Dw7) Ct 5300 |
| Ge Healthcare | $100.02 | 2024 | |
| Medtronic, INC. | $67.54 | 2023-2025 | Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $31.65 | 2025 | |
| Pfizer INC. | $18.75 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amro Alsaid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.